Cypress Capital, LLC Evogene Ltd. Transaction History

Cypress Capital, LLC

  • $388 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024
BUY
$0.61 - $0.82 $244 - $328
400 New
400 $0

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0
View Full List

About Evogene Ltd.

EVGN Quotes by TradingView
  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $69.6M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Cypress Capital, LLC Portfolio

Follow Cypress Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email